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Abstract
An intestinal protozoan parasite, Cryptosporidium parvum, is a major cause of waterborne
gastrointestinal disease worldwide. Detection of Cryptosporidium oocysts in potable water is a high
priority for the water treatment industry to reduce potential outbreaks among the consumer
populace. Anti-Cryptosporidium oocyst polyclonal and monoclonal antibodies were tested as
capture and detection reagents for use in a fiber optic biosensor assay for the detection of
Cryptosporidium oocysts. Antibodies were validated using enzyme-linked immunosorbent assays,
flow cytometry, Western blotting and fluorescent microscopy. Oocysts could be detected at a
concentration of 105 oocysts/ml when the polyclonal antibodies were used as the capture and
detection reagents. When oocysts were boiled prior to detection, a ten-fold increase in sensitivity
was achieved using the polyclonal antibody. Western blotting and immunofluorescence revealed
that both the monoclonal and polyclonal antibodies recognize a large (>300 kDa) molecular weight
mucin-like antigen present on the surface of the oocyst wall. The polyclonal antibody also reacted
with a small (105 kDa) molecular weight antigen that was present in boiled samples of oocysts.
Preliminary steps to design an in-line biosensor assay system have shown that oocysts would have
to be concentrated from water samples and heat treated to allow detection by a biosensor assay.
Background
Cryptosporidium parvum is an intestinal protozoan parasite
that continues to be a major cause of waterborne gastroin-
testinal disease worldwide. Detection and removal of
Cryptosporidium oocysts in potable water are high priori-
ties for the water treatment industry to reduce potential
outbreaks among the consumer populace. In the widely
publicized 1993 Milwaukee Cryptosporidium outbreak,
oocysts passed through the filtration system of one of the
city's water treatment plants and an estimated 403,000
people suffered from gastroenteritis [1]. The breakdown
of the filtration process was found to be related to high
turbidity values of the water. The United States Environ-
mental Protection Agency (EPA) regulatory approaches
for Cryptosporidium removal in drinking water are cur-
rently based on filtration with compliance met using tur-
bidity standards. Presently, detection of Cryptosporidium
oocysts in water using conventional microbial analysis is
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Although water leaving a treatment plant may initially be
safe for consumption, potable water supplies in the distri-
bution system are vulnerable to intentional contamina-
tion. An extended analysis period could lead to large
outbreaks of intestinal illness before either a break-
through event or intentional contamination occurrence is
detected. Therefore, there is a need for a rapid and auto-
mated assays targeted to detect potential pathogens in
drinking water.
Members of the genus Cryptosporidium are intracellular
coccidian parasites of mammals, birds, reptiles, and fish
[4]. Upon ingestion by a suitable host, oocysts undergo
excystation and release sporozoites into the intestine that
then infect the microvillous border of the epithelial cell
surfaces. Intracellular forms then undergo development
and eventually produce sporulated oocysts that are passed
from the host via feces. The intact oocyst is a thick-walled,
double-layered structure containing four sporozoites and
is resistant to chemical disinfectants including those used
by many water purification processes; thus, filtration is
the preferred method of removal [1,5].
For identification of breakthrough or intentional contam-
ination events in the distribution system, a real-time or
near-real-time detection system is needed that can operate
continuously and autonomously. Many systems are in
development for sampling and concentrating water from
the supply lines; however, for any of them to be success-
ful, they need to be coupled with biological detection sys-
tems such as biosensors. Biosensors have the potential to
meet the need for rapid, sensitive, and versatile microbial
detection systems. Fiber optic evanescent wave biosen-
sors, in particular, have been used to detect a wide variety
of molecules, including but not limited to fraction 1 anti-
gen of Yersinia pestis [6], Clostridium botulinum toxin A [7],
pseudexin and ricin toxin [8], trinitrotoluene (TNT),
[9,10], polymerase chain reaction-amplified DNA [11],
staphylococcal enterotoxin [12], and D-dimer [13]. In
addition, fiber optic evanescent wave biosensors have
been utilized to detect the human pathogens Listeria
monocytogenes [14,15], Salmonella enterica [16], and
Escherichia coli O157:H7 [17-20].
An automated evanescent wave biosensor (RAPTOR;
Research International, Monroe, WA.) has been selected
as an example for development of a Cryptosporidium assay.
The RAPTOR utilizes an analysis coupon that is easily pre-
treated to specifically target the pathogen of interest prior
to inserting it into the biosensor for sample testing. The
fiber optic biosensor assay is based on a sandwich immu-
noassay that utilizes antibodies or other molecules to cap-
ture the target pathogen from the sample matrix. The
captured target pathogen is then tagged with a cyanine 5-
labeled (Cy5) reporter antibody. A 635-nm laser diode
provides the excitation light that is passed through the
proximal end of each of the four injection-molded optical
polystyrene fiber optic waveguides contained in the cou-
pon. Fluorescent reporter antibodies within approxi-
mately 100–1000 nm of the waveguide surface are excited
by the evanescent field, and a portion of their emission
energy recouples into each fiber. A photodiode allows for
quantitation of the collected emission light at wave-
lengths above 650 nm. Emission from the Cy5 is recorded
in picoamperes (pA). The data are expressed as increases
in fluorescence proportional in magnitude to the target
pathogen concentration. Sample preparation is typically
minimal since particulate matter does not interfere with
the assay performance. The coupon can be reused for up
to 20 different assays as long as negative assay results are
obtained.
In this study, polyclonal and monoclonal anti-Crypt-
osporidium oocyst antibodies were used as capture and
detection molecules to develop an assay for detection of
Cryptosporidium oocysts using the automated evanescent
waveguide-based biosensor. Potentially, the automated
detection system could run autonomously in conjunction
with an in-line concentration unit to continuously test for
the presence of oocysts in a public potable water distribu-
tion system. A rapid automatic biosensor that effectively
detects Cryptosporidium oocysts in water distribution sys-
tems downstream of treatment facilities would be highly
desired by the water and public health industries.
This study focuses on problems and their solutions that
were encountered in the development of a rapid auto-
matic biosensor assay for detection of Cryptosporidium
oocysts in drinking water lines. This system exemplifies
the use of effective biology-based technologies (molecular
biology and immunology) applied to a societal need for
prevention of disease and bridges both biological and
environmental engineering disciplines.
Methods
Cryptosporidium parvum oocysts and antibodies
C. parvum oocysts of Iowa isolate, bovine, from experi-
mentally infected calves were purchased from Water-
borne, Inc. (New Orleans, LA) or from the Sterling
Parasitology Laboratory (University of Arizona, Tucson,
AZ). Oocysts were stored in 0.1 M phosphate-buffered
saline, pH 7.4 (PBS) at 4°C for no more than 6 weeks.
Oocysts were serially diluted using PBS before testing in
biosensor assays or enzyme-linked immunosorbent
assays (ELISAs).
An IgG1 subclass monoclonal mouse antibody specific to
the surface of Cryptosporidium oocyst walls [21] and a pol-
yclonal rabbit antibody raised against the same antigenPage 2 of 11
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tralia). Antibodies were tested as capture and detection
molecules for use in ELISA and evanescent waveguide-
based biosensor assays targeted to detect Cryptosporidium
oocysts. For biosensor assays, antibodies were diluted,
labeled with biotin or cyanine 5 (Cy5), and purified as
previously described [19].
Pre-treatment of oocysts
In many experiments, oocysts were treated prior to use in
ELISAs, sodium-dodecyl-sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE), or biosensor assays. Certain
conditions such as addition of sodium taurocholate at
37°C have been reported to optimize excystation of iso-
lates of Cryptosporidium in cell culture [22-25]. Treatments
included the addition of sodium taurocholate (bile) or
sodium dodecyl sulfate (SDS) at 5–10% final concentra-
tion and/or incubations at 37°, 50°, 60°, 75°, or 100°C
(boiled) for 30 sec to 20 minutes and/or freeze-thawing
the oocysts at -80°C six times. In some cases, oocysts
boiled for 10 min were separated into a soluble fraction
and an insoluble fraction by centrifuging treated oocysts
for 10 min at 16,000 × g, 4°C, using an Eppendorf 5415R
centrifuge (Brinkmann Instruments, Inc., Westbury, NY).
The supernatant fluid was collected into a separate tube
(soluble fraction) and the pellet was resuspended to the
sample's original volume using PBS (insoluble fraction).
Enzyme-linked immunosorbent assays (ELISAs)
Both the polyclonal and the monoclonal anti-Crypt-
osporidium oocyst antibodies, were evaluated for detection
of C. parvum oocysts using ELISA. Volumes of 100 µl of all
reactants were added to duplicate wells of 96-well micro-
plates (Nunc MaxiSorp®, Nalge Nunc International,
Rochester, NY). Serial dilutions of control or pre-treated
oocysts were adsorbed to wells of plates for 18 h at 4°C.
All further incubations were performed at 24°C. Wells
were washed one time with PBS containing 0.1% Tween
20 (PBST) and blocked using blocking buffer (2 mg/ml
casein, 2 mg/ml bovine serum albumin (BSA) in PBS).
Plates were washed again, and dilutions of primary anti-
body (anti-Cryptosporidium oocyst monoclonal or polyclo-
nal antibody) in blocking buffer were incubated in wells
for 30 min. Wells were then washed three times with
PBST, and horseradish peroxidase-labeled secondary anti-
body, anti-rabbit IgG or anti-mouse IgG (Kirkegaard &
Perry Laboratories Inc., Gaithersburg MD) at a 1:1000
dilution in blocking buffer was added and incubated for
30 minutes. Wells were washed three times with PBST,
and QuantaBlue reporter substrate was added (Pierce Bio-
technology, Rockford, IL), followed by a 15 min incuba-
tion period. QuantaBlue stop solution was then added
and fluorescence, detected as relative fluorescence units
(RFU), was measured at 325 nm excitation and 420 nm
emission using a Spectra Max Gemini XS fluorometer
(Molecular Devices, Sunnyvale, CA). All ELISAs were per-
formed at least two times using duplicate wells for each
parameter tested. The signal to noise (S/N) ratio was cal-
culated by dividing the mean RFU for the sample test
wells by the negative control mean RFU. The negative con-
trol wells contained all additions except oocysts or pri-
mary antibody. Detection was considered positive when
the S/N ratio was a minimum of 2.0.
SDS-PAGE and Western blot
SDS-PAGE was conducted on 3–8% Tris-acetate gels
(NuPage, Invitrogen Life Technologies, Carlsbad, CA)
using Tris-Tricine running buffer (NuPage). Samples of
boiled oocysts and control oocysts were loaded directly
onto the gel or were reduced by 5 mM Tri-n-butyl phos-
phine (TBP, Sigma Aldrich, St. Louis, MO) before loading.
After SDS-PAGE, gels were electrotransferred using a mini-
Protean II blotter (BIORAD, Inc. Hercules, CA) to 0.22 µm
pore size PVDF membranes (Millipore Corp., Bedford,
MA) and membranes were blocked for 30 minutes at
24°C using 5% skim milk plus 5% bovine serum albumin
(Sigma) in PBS. Membranes were incubated with either
the anti-Cryptosporidium oocyst polyclonal or monoclonal
antibody at a concentration of 5 µg/ml for 30 minutes at
24°C. After washing membranes with PBS, bound anti-
bodies were detected using 0.5 µg/ml alkaline phos-
phatase conjugated goat anti-rabbit IgG or alkaline
phosphatase conjugated sheep anti-mouse IgG (Sigma)
incubated for 30 min at 24°C. After washing, membranes
were developed using Sigma FAST™ 5-bromo-4-chloro-3-
indolyl phosphate/nitro blue tetrazolium according to the
manufacturer's instructions.
Fluorescent microscopy
To avoid exposing oocysts to heat, oocysts were labeled
with polyclonal antibody using the following filtration
method. Volumes of 100 µl of all reactants were added to
96-well filter plates (Mulitscreen-BV, 1.2 µm hydrophilic
low protein binding Durapore membrane; Millipore
Corp.). All incubations were performed at 24°C. Control
or boiled oocysts were added to wells, and vacuum was
applied to remove liquid. Blocking buffer was added to
oocysts in wells, and primary antibody (anti-Cryptosporid-
ium oocyst polyclonal antibody, 5 µg/ml) was added and
incubated for 30 min. Vacuum was applied to the wells
and the wells were then washed three times with PBS.
Fluorescein-5-isothiocyanate (FITC)-labeled secondary
antibody, anti-rabbit IgG (Sigma) at 1:500 dilution in
blocking buffer, was added and incubated for 30 min.
Oocysts were also prepared without primary antibody as
a negative control. Vacuum was again applied to the wells,
and wells were washed three times with PBS. Oocysts were
then resuspended in PBS, added to microscope slides and
covered with coverslips. In addition, samples of boiled,Page 3 of 11
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cently labeled with polyclonal and monoclonal antibody
by mixing with FITC labeled polyclonal or monoclonal
antibody at a concentration of 5 µg/ml in PBS plus 1%
BSA and leaving at 24°C for 15 min. A drop of the stained
samples was placed onto microscope slides and a cover-
slip applied. The oocysts were viewed under light and epi-
fluorescence microscopy (Olympus BX 60, Olympus
America, Inc., Lake Success, NY) using a U-MWIBA filter.
Photographs were taken at 400× magnification with an
Olympus Q Color 3 cooled camera. Image contrast was
adjusted using picture brightness/contrast feature of
Microsoft Word program to darken field background in
order to visualize cells.
Flow cytometry
Samples (50 µl) of boiled and control oocysts were mixed
with 100 µl aliquots of concentrated filter backwash water
from a water treatment plant. The backwash water sample
was prepared by collecting 20 L of water from the back-
wash cycle of a filter bed at a local treatment plant (Rich-
mond, Sydney). The sample was allowed to settle for 48 h
at 4°C and supernatant fluid carefully removed. The
remaining 1 L volume was stored at 4°C until used. The
backwash concentrate was added to simulate the back-
ground that might be encountered with testing of a real
water sample. The samples were mixed with the mono-
clonal or polyclonal antibody that had been conjugated
with fluorescein isothiocynate as described previously
[26] at a final concentration of 10 µg/ml in PBS plus 0.5%
(w/v) bovine serum albumin. After 10 minutes incuba-
tion at 24°C, the samples were analyzed using a Becton
Dickinson FACScalibur flow cytometer. The threshold
was set on green fluorescence (FL1) and the entire sample
was analyzed. Data were displayed on a scatter plot of FL1
(y axis) and forward scatter (x axis).
Biosensor instrument and waveguide preparation
The RAPTOR Plus 4S (RAPTOR) is a portable, automatic
fiber optic biosensor manufactured by Research Interna-
tional (Monroe, WA). Polystyrene waveguides, 4.5 cm in
length, used with the RAPTOR and produced by Research
International, were sonicated for 30 sec in an isopropanol
bath. Waveguides were rinsed with deionized water; the
distal tip of the waveguide was dipped in black paint to
provide a light dump. After the paint dried, waveguides
were added to glass capillary tube-incubation chambers
and were incubated at 4°C for 18 to 22 h with 100 µg/ml
streptavidin (Sigma). Waveguides were rinsed with PBST,
added to clean glass capillary tube-incubation chambers
and incubated with 100 µl of 100 µg/ml biotinylated anti-
body in PBS (capture antibody) at 24°C for 30 min. The
capture antibody solution was replaced with fresh solu-
tion and incubated an additional 30 min. Four
waveguides coated with capture antibody were then glued
into each RAPTOR coupon which was sealed with sealing
tape and label added. The RAPTOR was programmed to
run automatically using a start-up recipe and a sample rec-
ipe. The start-up recipe was used at the beginning of each
experiment and consisted of the following steps. The four
waveguides were rinsed with an equivalent of 2 ml of
PBST two times. The 635 nm diode laser was then acti-
vated, and the pA signal was recorded after 5 sec. The sam-
ple recipe was used to take baseline (blanks) and sample
readings and consisted of incubating each of the four
waveguides with a different 0.2 ml sample for five min,
followed by incubating each waveguide with an addi-
tional 0.2 ml sample for five min. The waveguides were
then rinsed with PBST; detection antibody was added and
incubated for five min. The detection antibody was then
returned to the holding vessel via the internal pump sys-
tem. Waveguides were rinsed twice with PBST. The 635
nm diode laser was activated while PBST was sitting in the
coupon channels, and the pA signal was recorded after 5
sec. PBST was then discarded to waste. All automated
assays were carried out at 24°C.
Baseline readings
Six baseline readings were taken for each coupon tested.
Detection antibody consisted of Cy5-labeled monoclonal
anti-Cryptosporidium oocyst antibody, 10–20 µg/ml in
detection buffer (2 mg/ml casein, 2 mg/ml bovine serum
albumin in PBS). The pA value for each baseline reading
was subtracted from the subsequent baseline reading; the
calculated value was designated as the ∆pA previous signal
for baselines 2 through 6. The detection limit was calcu-
lated as the mean ∆pA previous signal for baselines 2
through 6 (mean baseline value) plus three times the
standard deviation.
Biosensor sensitivity assay
A sample of PBS with or without Cryptosporidium oocysts
in a volume of 0.4 ml was added to four 1.5 ml tubes.
Sample tubing from the RAPTOR was inserted into each of
the 4 sample tubes, and the "run assay" button was
pushed. The RAPTOR automatically ran a sample recipe as
described previously. When the first sample was tested,
the last baseline reading was subtracted from the sample
reading. When additional samples were tested, each previ-
ous sample reading was subtracted from the next sample
reading. These calculated values for the samples were des-
ignated as the change in pA from previous signal for each
sample. At least two waveguides were tested in each assay,
and at least triplicate samples for each oocyst concentra-
tion were tested on each waveguide. All assays were per-
formed at least two times.Page 4 of 11
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Effect of oocyst pre-treatment on antibody binding
The anti-Cryptosporidium polyclonal antibody was first
evaluated for detection of Cryptosporidium oocysts using
ELISA. Oocysts tested were either control or boiled, freeze/
thawed, or incubated with 5% bile or SDS at 37°C. At
least a five-fold higher S/N ratio was obtained when the
polyclonal antibody was bound to boiled or freeze/
thawed treated oocysts as compared to control (Figure 1).
Treatment of oocysts with bile or SDS also improved the
antibody binding affinity; S/N ratios were approximately
three-fold higher than those for untreated oocysts. Shorter
boiling times as low as two minutes gave similar results to
the ten minute treatment (data not shown). Lower tem-
perature treatments of 50°, 60°, 75°C for 10 minutes also
improved antibody binding to oocysts by 1.5-, 2.4-, and 4-
fold, respectively, suggesting that oocyst heat treatment
increases antibody binding to the oocysts. A 10 minute
incubation at 37°C gave similar ELISA results compared
with the untreated control oocysts (data not shown).
Boiled oocysts were then divided into soluble and insolu-
ble fractions by boiling the oocysts, centrifuging and col-
lecting the supernatant fluid (soluble fraction) and
resuspending the centrifuged pellet in PBS (insoluble frac-
tion). The aggregate boiled sample and soluble fraction
produced similar S/N ratios and were at least four times
higher than that of the unboiled control. (Figure 2). The S/N ratio for the insoluble fraction was three-fold higher
than the control, but half that of the whole or soluble por-
tion of the sample.
The monoclonal antibody was then tested using ELISA as
described to determine whether boiled oocysts gave
higher S/N ratios as previously observed for the polyclo-
nal (Figure 3). In contrast to results obtained with poly-
clonal antibody, the monoclonal antibody produced no
significant difference in S/N ratios for boiled oocysts as
compared to control. The result was the same irrespective
of antibody concentration tested.
C. parvum oocyst antigen detection by polyclonal 
antibody
A Western blot of oocysts was performed in order to deter-
mine whether the polyclonal antibody was binding to dif-
ferent antigens in soluble and insoluble oocyst fractions.
Both the polyclonal and monoclonal antibodies recog-
nized a large (>300 kDa) molecular weight antigen that
appeared as two bands in the boiled oocyst samples (Fig-
ure 4). The polyclonal antibody also reacted with a 105
kDa antigen from the soluble fraction of the boiled
oocysts. The monoclonal antibody did not react with the
105 kDa molecular weight antigen. Results were similar
for both reduced and non-reduced samples.
ELISA detection of soluble and insoluble antigens of boiled C. parvum oocystsFigure 2
ELISA detection of soluble and insoluble antigens of 
boiled C. parvum oocysts. Oocysts were control, boiled 
for 10 minutes, or boiled 10 minutes and separated into 
insoluble fractions and soluble fractions by centrifugation. 
Oocysts were then detected using anti-Cryptosporidium poly-
clonal antibody (1.25 µg/ml). Error bars represent one stand-
ard deviation. Signal to noise values above 2 are considered 
positive.
Effect of C. parvum oocyst pre-treatments on the binding of polycl nal anti-Cryptosporidium antibody as determined by LISAFigure 1
Effect of C. parvum oocyst pre-treatments on the 
binding of polyclonal anti-Cryptosporidium antibody 
as determined by ELISA. Oocysts (105 oocysts/well) 
were tested as control, frozen and thawed six times, boiled 
for 10 minutes, or incubated at 37°C in 5% bile or in 5% SDS. 
Error bars represent one standard deviation and fall within 
the symbols for each point. Signal to noise values above 2 are 
considered positive. The standard deviation for the noise 
(PBS control wells) was 0.07.Page 5 of 11
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Analysis of control and boiled oocysts that had been
stained with FITC labeled monoclonal or FITC labeled
polyclonal antibody demonstrated a slight decrease in flu-
orescence after boiling (Figure 5). The separation between
the oocysts and the debris particles represented the S/N
ratio for this type of analysis. The S/N ratio did not change
notably with any of the samples.
Antibody binding analysis by fluorescent microscopy
Boiling and other oocyst treatments could possibly release
internal antigens from the oocysts that are recognized by
the polyclonal antibody. This release could be causing the
increase in ELISA S/N ratio with the polyclonal antibody.
Fluorescent microscopy was used to examine samples of
control, boiled, freeze thawed and excysted oocysts. Uni-
form fluorescence of the oocyst wall with no internal flu-
orescence was observed in all samples (data not shown for
freeze thawed and excysted oocysts). The boiled oocyst
sample appeared slightly more fluorescent than the other
samples (Figure 6).
Biosensor assays
For each experiment four samples of oocysts suspended in
PBS were automatically injected into a coupon prepared
with polyclonal anti-Cryptosporidium antibodies as the
capture molecule. For detection, either Cy5-labeled poly-
clonal or monoclonal detector antibodies were used. The
average detection limits for waveguides tested using poly-
clonal antibody and monoclonal antibody were 89 and
110, respectively. Values for ∆pA from previous signal that
are above the detection limit are considered positive for
the detection of Cryptosporidium oocysts. When polyclonal
antibody was used as both the capture and detector mole-
cule, boiled oocysts were detected at 105 oocysts/ml con-
centrations, whereas control oocysts (not boiled) were
detected at 106 oocysts/ml concentrations (Figure 7A).
When the monoclonal antibody was used as the detector
molecule, the lowest concentration of boiled oocysts
detected was 106 oocysts/ml (Figure 7B), but the values for
the change in pA from the previous signal for detection of
106 oocysts/ml using the Cy5-labeled monoclonal anti-
body were not significantly higher than the signals
obtained with samples containing only PBS.
Discussion
As reported waterborne outbreaks of cryptosporidiosis
have increased over the last few years, and as new regula-
tions have been implemented, interest in detecting Crypt-
osporidium in water has grown. Many articles have been
written that focus on various methods for detecting
oocysts in water (see reviews [27,28]), yet most if not all
deal with methods that rely upon grab samples, without
the potential for advancing to in-line detection. Develop-
ment of an assay to be used on a biosensor is the initial
step to producing an automated system for in-line detec-
tion of Cryptosporidium oocysts in potable water. As
described herein, a RAPTOR biosensor was used to
develop an assay targeted to detect Cryptosporidium oocysts
in water as a step towards producing an autonomous sys-
tem.
As polyclonal antibodies are known to be effective capture
molecules, and monoclonal antibodies have been widely
used as reporter molecules, they were produced by a pat-
ented technique that involves immunizing mice or rabbits
with semi-solubilized oocyst wall antigen [21] and the
resulting anti-Cryptosporidium oocyst antibodies were eval-
uated. Because bile treatment is frequently used to opti-
mize excystation of oocysts [22-25], bile was tested in
addition to SDS to try to improve S/N ratios. Treatment of
oocysts with bile or SDS improved the S/N ratio as com-
pared to controls but not as significantly as temperature
treatments. The higher ratios obtained for boiled oocysts
as compared to those treated with bile or SDS suggested
that oocyst excystation alone was not responsible for the
improved antibody binding. Boiling the oocysts may
release additional immunogenic proteins from the
oocysts or may denature or degrade proteins so that they
are more readily accessible for polyclonal antibody bind-
ing, thereby producing a higher signal.
Monoclonal and polyclonal anti-Cryptosporidium antibody binding to boiled C. parvum oocyst antigensFigure 3
Monoclonal and polyclonal anti-Cryptosporidium anti-
body binding to boiled C. parvum oocyst antigens. 
Oocysts (105 oocysts/well) were held as control or boiled for 
10 minutes and then analyzed using polyclonal antibody or 
monoclonal antibody in an ELISA: control poly; control 
mono; boiled poly; boiled mono. Error bars represent one 
standard deviation and fall within the symbols for each point. 
Signal to noise values above 2 are considered positive. The 
standard deviation for the noise (PBS control wells) was 0.10 
and 0.07 for the polyclonal and monoclonal antibodies, 
respectively.Page 6 of 11
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cation/concentration step and typically presumptive
oocysts are sorted out of the water and confirmed by man-
ual microscopy [29]. When the polyclonal antibody was
tested using flow cytometry, control oocysts generated
greater fluorescence signals than boiled oocysts. Detection
using flow cytometry is based on size and, thereby, solu-
bilized analytes released by boiling were excluded from
detection. In ELISA assays, oocysts and any associated free
antigens were adsorbed to the bottom of wells in 96-well
plates. Therefore, antibody could bind to any or all anti-
gens present or possibly adsorbed to the plastic, including
solubilized antigens, and a greater signal is produced. To
test this hypothesis, boiled oocysts were divided into sol-
uble and insoluble fractions and retested. ELISAs showed
that the polyclonal antibody did bind to soluble antigens
found in the soluble fraction. Boiling and freeze/thawing
most likely disassociated antigens from the oocyst,
thereby allowing antibodies to have greater access to
oocyst antigens. These soluble antigens could be detected
using ELISA, but could not be detected using flow cytom-
etry.
Analysis by Western blotting revealed that both the poly-
clonal and monoclonal anti-Cryptosporidium antibodies
recognize a large (>300 kDa) antigen. Analysis of the sol-
uble fraction of boiled oocysts revealed that a small (105
kDa) antigen was released by boiling the oocysts. This
antigen was recognized by the polyclonal antibody but
not by the monoclonal antibody. It is unknown whether
this small antigen is released from the boiled oocysts or is
a fragment of the larger antigen but its presence in the sol-
uble fraction may account for the differences in signal
between ELISA and flow cytometry analysis.
The fiber optic biosensor only excites the fluorophore of
fluorescently tagged reporter antibodies present within
the evanescent field generated 100 nm to 1000 nm from
the surface of the fiber optic waveguide [30,31]. The fluo-
rescently tagged antibodies binding to the majority of
antigens on the surface of the unboiled larger oocysts (4–
6 µm diameter) are not within the evanescent field and
thus are not excited. Only the portion bound to the
oocysts closest to the surface are detected by the biosen-
sor, which results in poorer sensitivity. The smaller solu-
Analysis of Cryptosporidium oocyst antigens by Western blottingFigure 4
Analysis of Cryptosporidium oocyst antigens by Western blotting. Samples of boiled/reduced and control oocysts 
were electrophoresed by SDS-PAGE and the blotted membranes were probed with either polyclonal or monoclonal anti-Crypt-
osporidium FITC labeled antibody.Page 7 of 11
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Western blot, are more likely to be located within the eva-
nescent field of the biosensor due to their small size.
When these smaller analytes are bound by Cy5-labeled
detection antibodies, the Cy5 is excited, and the smaller
analytes are detected by the biosensor in addition to the
bound oocysts, thus increasing signal. The larger portion
of the Cy5 antibodies excited by the evanescent field
results in an increase in pA signal and ultimately an
increase in sensitivity.
Flow cytometry and fluorescence microscopy revealed
that not all the antigen was removed from the oocyst sur-
face by boiling. The boiled oocysts were slightly more flu-
orescent than the control oocysts and they were
considerably more fluorescent than the debris particles
present in the filter backwash water. This increase in fluo-
rescence indicates that more antigen was accessible for
binding although it was still adhered to the surface. This
difference would suggest that the sensitivity of the biosen-
sor could be increased considerably if a method for com-
plete removal of the oocyst antigen prior to detection were
developed. Complete removal of the antigen would allow
for better binding due to size differential and possibly
more complete coverage of available binding surface area.
In addition, the results demonstrate that flow cytometry is
not always a suitable tool for screening antibodies, partic-
ularly if antibodies are being screened for other applica-
tions (e.g., capture molecules on biosensor). With flow
cytometry, the S/N ratio was significantly higher when
monoclonal antibody was bound to control oocysts than
Analysis of polyclonal and monoclonal antibody binding to boiled and unboiled C. parvum oocysts using flow cytometryFigure 5
Analysis of polyclonal and monoclonal antibody binding to boiled and unboiled C. parvum oocysts using flow 
cytometry. Particle size (x-axis) vs fluorescence (y-axis) is depicted by the forward scatter. The top plots present polyclonal 
antibody binding to either control (A) or boiled (B) oocysts and the bottom plots present monoclonal antibody binding to 
either control (C) or boiled (D) oocysts. The small red population represents the fluorescent oocysts and the larger curved 
population represents debris particles present in the water sample.Page 8 of 11
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treated oocysts. This is in direct contrast to results
obtained by ELISA method and biosensor assay, which
showed the highest S/N ratio for boiled oocysts bound to
polyclonal antibody. These results reaffirm that ELISA is a
suitable method for evaluating antibodies for use in the
biosensor assay.
The biosensor assay described herein is a first step towards
an automated detection system for Cryptosporidium in
water distribution systems. The results indicate that
although current biosensor detection limits are high as
compared to EPA regulations, there are ways of increasing
sensitivity. The infectivity of C. parvum oocysts has been
investigated in healthy adults and, although C. parvum
isolates have been shown to differ in their infectivity, as
few as 9 oocysts were reported to produce infection in
Epifluorescent images of polyclonal anti-Cryptosporidiu m antibody binding to oocyst wallsFigure 6
Epifluorescent images of polyclonal anti-Cryptosporidiu m antibody binding to oocyst walls. Oocysts were labeled 
with rabbit polyclonal antibody, which was then tagged with FITC-labeled anti-rabbit IgG. Oocysts were viewed and imaged 
using bright field and an Olympus UM-WIBA FITC fluorescence filter (400× magnification).Page 9 of 11
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Journal of Biological Engineering 2007, 1:3 http://www.jbioleng.org/content/1/1/350% of individuals [32,33]. The Cryptosporidium biosensor
assay using polyclonal antibody was capable of detecting
boiled oocysts at 106/ml concentration. Oocysts can occur
in drinking water at minimum infectious dose levels
(approximately 1 oocyst/ml) and, therefore, would not be
detected using the described assay. However, appending
the biosensor to an upstream concentration/pretreatment
step would allow detection at clinically relevant levels. To
develop an automated in-line biosensor for oocyst detec-
tion, a very simple oocyst treatment to optimize antibody
binding would be required. A high temperature oocyst
treatment could easily be incorporated and automated in
conjunction with a concentrator. The concentrator would
increase the number of oocysts present in a sample, fol-
lowed by an in-line heat exchanger to treat the concen-
trated oocysts before being presented to the biosensor for
testing. Unfortunately, the high temperature treatment
would destroy oocyst viability, thereby preventing recov-
ery and culture of oocysts from the waveguide for con-
firmatory testing. Therefore, each time a positive result is
obtained from the biosensor, an aliquot of the pre-boiled
sample would have to be collected and stored for confir-
mation. Development of an automated, in-line concentra-
tion and detection system for microorganisms is presently
in progress. The system in development could easily be
adapted for concentration and heating of oocysts, fol-
lowed by oocyst detection using the biosensor assay.
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